Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Agilent Technologies

Stocks With Rising Relative Strength: Agilent Technologies

Agilent Technologies shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Is Agilent Technologies Stock Underperforming the S&P 500?

Despite Agilent Technologies’ recent underperformance relative to the S&P 500 Index, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Expert Outlook: Agilent Technologies Through The Eyes Of 4 Analysts

Throughout the last three months, 4 analysts have evaluated Agilent Technologies (NYSE:A), offering a diverse set of opinions from bullish to bearish.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

How Is Agilent Technologies’ Stock Performance Compared to Healthcare Stocks?

Agilent Technologies has underperformed the healthcare sector lately, and analysts are moderately optimistic about the stock’s potential.

Barchart

What Are Wall Street Analysts' Target Price for Agilent Technologies Stock?

As Agilent Technologies underperformed relative to the S&P 500 Index over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Barchart

What to Expect From Agilent Technologies' Q3 2024 Earnings Report

Agilent Technologies is poised to release its third-quarter results next month, and analysts are projecting a single-digit earnings decline.

Barchart

Agilent Technologies Stock Getting Closer To Key Technical Benchmark

A Relative Strength Rating upgrade for Agilent Technologies shows improving technical performance. Will it continue?

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

3 Medical Stocks Set to Soar in 2024

The healthcare industry in 2024 is shaped by personalized medicine and innovative technologies in pharmacy, diagnostic testing, and medical devices. Hence, fundamentally strong medical stocks CVS Health (CVS), Agilent Technologies (A), and MiMedx Group (MDXG) could garner significant gains in the upcoming year. Read more….

StockNews.com

Uncovering the Investment Prospects of Agilent Technologies (A) and Medtronic (MDT)

The medical industry is poised for growth with technological advancements, increasing disease rates, and government support. Therefore, let's assess the investment prospects of leading medical stocks Agilent Technologies (A) and Medtronic (MDT). Read more….

StockNews.com

Building Wealth with Spinoffs: How Adding These Gems Can Transform Your Portfolio

Spinoffs are value creating investment opportunities. You should be looking at them

Barchart

Agilent empowers Thailand’s research frontier

Agilent Technologies, a global laboratory technology provider, is driving growth in the Thai market where research investment is burgeoning through the support of new advanced technologies and collaboration with local partners.

Bangkok Post

Agilent Technologies Whale Trades Spotted

Someone with a lot of money to spend has taken a bullish stance on Agilent Technologies (NYSE:A). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022

Benzinga

Here's How Much $100 Invested In Agilent Technologies 5 Years Ago Would Be Worth Today

Agilent Technologies (NYSE:A) has outperformed the market over the past 5 years by 5.5% on an annualized basis producing an average annual return of 15.19%. Currently, Agilent Technologies has a market capitalization of $35.66 billion.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Agilent Technologies Down Almost 30% In 2022, Is Now Time To Buy?

Shares of the medical diagnostics and research company Agilent Technologies (A) have plunged nearly 30% year-to-date. However, Wall Street analysts see significant upside potential in the stock, given its solid fundamentals. So, is the stock a buy now? Read on to find out.

Benzinga

How Is The Market Feeling About Agilent Technologies?

Agilent Technologies's (NYSE:A) short percent of float has fallen 32.77% since its last report. The company recently reported that it has 3.55 million shares sold short, which is 1.19% of all regular shares that are available for trading.

Benzinga

Here's How Much $100 Invested In Agilent Technologies 10 Years Ago Would Be Worth Today

Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 4.24% on an annualized basis producing an average annual return of 16.21%. Currently, Agilent Technologies has a market capitalization of $37.86 billion.

Benzinga

$1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much

Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 3.86% on an annualized basis producing an average annual return of 15.33%. Currently, Agilent Technologies has a market capitalization of $37.67 billion.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Agilent Technologies's Earnings: A Preview

Agilent Technologies (NYSE:A) is set to give its latest quarterly earnings report on Tuesday, 2022-05-24. Here's what investors need to know before the announcement. Analysts estimate that Agilent Technologies will report an earnings per share (EPS) of $1.07.

Benzinga

Peering Into Agilent Technologies's Recent Short Interest

Agilent Technologies's (NYSE:A) short percent of float has risen 30.22% since its last report. The company recently reported that it has 5.41 million shares sold short, which is 1.81% of all regular shares that are available for trading.

StockNews.com

Thermo Fisher Scientific vs. Agilent Technologies: Which Diagnostics & Research Stock is a Better Buy?

Integration of advanced technologies and analytics to early diagnosis of chronic diseases have helped companies engaged in the medical diagnostics and research industry gain wide market reach. This growing demand and rising investments should help prominent players in this space, Thermo Fisher Scientific (TMO) and Agilent Technologies (A), benefit. But…

Benzinga

If You Invested $1000 In Agilent Technologies 15 Years Ago, Here's How Much You Would Have Today

Agilent Technologies (NYSE:A) has outperformed the market over the past 15 years by 1.03% on an annualized basis producing an average annual return of 8.21%. Currently, Agilent Technologies has a market capitalization of $36.29 billion.

Benzinga

Analyst Ratings for Agilent Technologies

Within the last quarter, Agilent Technologies (NYSE:A) has observed the following analyst ratings:

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022

Benzinga

Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years

Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 3.57% on an annualized basis.

1 2

People

Kritika SarmahHer

727 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.